Melanoma
News
BRAF Inhibitor Cuts Death Risk in Advanced Melanoma
Major Finding: Survival estimates at a median 3 months’ of follow-up suggest 84% of patients treated with vemurafenib would be alive at 6 months...
News
BRAF Inhibitor Cuts Death Risk in Advanced Melanoma
Major Finding: Survival estimates at a median 3 months’ of follow-up suggest 84% of patients treated with vemurafenib would be alive at 6 months...
News
DANBIO: Anti-TNFs Do Not Up Overall Cancer Risk in Arthritis
Major Finding: The relative risk of developing a first cancer with anti-TNF therapy vs.
News
Ipilimumab and Beyond: New Therapies Imminent in Melanoma
News
Lymphatic Invasion Predicts Recurrence in Merkel Cell Cancer
Major Finding: The presence of lymphovascular invasion was significantly associated with both nodal or distant recurrence and death from Merkel...
News
FDA Approves Peginterferon Alfa-2b for Melanoma
News
Thin vs. Thick Melanomas: Both Carry Same SLN Involvement Risk
Major Finding: A positive sentinel lymph node was identified in 8.2% of patients with thin melanomas and positive deep margins vs.
News
Once Again, Results Mixed for SN Biopsy in Melanoma
Major Finding: Sentinel node biopsy significantly prolonged disease-free survival, but not distant metastases free- or melanoma-specific survival....